In vivo XPAT protein unmasking was assessed in five PDX tumor models with HER2-XPAT protein and an additional five PDX models with an XPAT prototype targeting human EpCAM (EpCAM-XPAT) (Supplementary Table 3). Here, EPCAM is linked to neoplasm.